Earnings Preview For ADMA Biologics
Portfolio Pulse from Benzinga Insights
ADMA Biologics (NASDAQ:ADMA) is scheduled to release its quarterly earnings report on February 28, 2024, with an expected EPS of $0.02. Historical data shows positive stock price movements following earnings beats. Shares have increased by 53.77% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.
February 27, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ADMA Biologics is expected to report an EPS of $0.02 for the upcoming quarter, with historical performance indicating potential positive stock movement post-earnings.
ADMA Biologics has shown a pattern of stock price increases following earnings beats in previous quarters. With an expected EPS of $0.02 and historical data indicating positive reactions to earnings beats, there is a strong likelihood of a positive short-term impact on ADMA's stock price, especially considering the 53.77% increase over the last 52 weeks.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100